Back to Search Start Over

Multicentre, randomised, double-blinded, active-controlled, cross-over phase 3 trial on safety and efficacy of rFVIIa analogue (vatreptacog alfa) in haemophilia patients with inhibitors (adept (TM)(2))

Authors :
Lentz, S. R.
Mahlangu, J.
Karim, Abdul F. A.
Andreeva, T.
Economou, M.
Ehrenforth, S.
Jerzy Windyga
Source :
Web of Science, Publons

Details

Database :
OpenAIRE
Journal :
Web of Science, Publons
Accession number :
edsair.dedup.wf.001..4ed6a33d113a226aa12ea050f17cea2b

Tools

Authors Abstract Subjects Details